Literature DB >> 20598408

Surveillance of adverse events following immunization against pandemic influenza in Slovenia in season 2009/10.

Alenka Kraigher1, Veronika Ucakar.   

Abstract

The results of Slovenian surveillance system of AEFI which was in place for the early detection and investigation of rare adverse events were analysed. The reports about AEFI obtained from physicians, and self-assessment questionnaires from vaccinated persons showed predominantly non-serious and expected side effects. Nine reports (3%) included serious AEFI. No deaths consequent to vaccination were reported. A total of 1170 AEFI were reported by physicians and 1030 by self-assessment. Overall, the most commonly reported AEFI either by physicians or persons were local site reactions (37.3% and 50.5%), tiredness (11.9% and 6.8%) and fever or malaise (10.8% and 6.3%). More than 100,000 people were vaccinated with pandemic vaccines in Slovenia. The type and the frequency of AEFI detected through Slovenian AEFI surveillance system are comparable to the results from other surveillance systems. The benefit-risk balance for the pandemic vaccines used in Slovenia remains positive. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20598408     DOI: 10.1016/j.vaccine.2010.05.066

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Acceptance of Seasonal Influenza Vaccination Among Slovenian Physicians, 2016.

Authors:  Veronika Učakar; Alenka Kraigher
Journal:  Zdr Varst       Date:  2019-01-21

2.  Short and long-term safety of the 2009 AS03-adjuvanted pandemic vaccine.

Authors:  Gaston De Serres; Marie-Claude Gariépy; Brenda Coleman; Isabelle Rouleau; Shelly McNeil; Mélanie Benoît; Allison McGeer; Ardith Ambrose; Judy Needham; Chantal Bergeron; Cynthia Grenier; Kenna Sleigh; Arlene Kallos; Manale Ouakki; Najwa Ouhoummane; Grant Stiver; Louis Valiquette; Anne McCarthy; Julie Bettinger
Journal:  PLoS One       Date:  2012-07-03       Impact factor: 3.240

3.  Monitoring the safety of influenza A/H1N1 pandemic and seasonal vaccines in Morocco.

Authors:  Amina Tebaa; Raja Benkirane; Loubna Alj; Imad Cherkaoui; Rachida Soulaymani-Bencheikh
Journal:  Ther Adv Vaccines Immunother       Date:  2022-03-29

4.  Use of a text message-based pharmacovigilance tool in Cambodia: pilot study.

Authors:  Sophie Baron; Flavie Goutard; Kunthy Nguon; Arnaud Tarantola
Journal:  J Med Internet Res       Date:  2013-04-16       Impact factor: 5.428

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.